The Cigna Group (CI)

From the record

The Cigna Group's filings since 2018 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

The Cigna Group's 10 filed years say what it did: revenue went from $40 billion in fiscal 2016 to $275 billion in fiscal 2025, up 23.9% a year; it rose in 9 of 9 years; it never fell from a peak; net income was positive in 10 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, The Cigna Group's diluted share count shrank about 5.0% a year, and dividends and buybacks returned about 55% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 20 sales (19 under scheduled 10b5-1 plans) and 1 purchase of their own stock on the open market in the year to 2026-09-30, buying about $1000 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, The Cigna Group earned about 15 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 38 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 73 cents per dollar of assets, and net share issuance: its share count shrank 5.2% over the year (the filed statements).

From the record

The Cigna Group's standing among 10 graded names in its industry family: revenue of $275 billion in fiscal 2025 ranks in the top 15% by size; a net margin of 2.3% ranks in the top 25%; revenue growth of 15% a year over the last 3 filed years ranks in the top 45% (its annual reports).

From the record

The Cigna Group's leadership, from its insiders' filings and its current reports: the chief executive on the record is Evanko, Brian C (President and Chief Executive Officer, as filed), filing under that title since 2026-09-03, 2 months (bottom 6% of its family); the 24 officers and directors filing in the last fifteen months have been on the record a median of 5.5 years (top 39%); 11 officer or director changes were reported on Form 8-K since 2023-11-13, against the 24 people in charge now (bottom 35%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

The Cigna Group's room to grow, from the newest filed statements (fiscal 2025): cash of $7.7 billion against debt of $31 billion leaves -14.7% of its assets as net cash, bottom 35% of its family; cash from operations less capital spending is 3.5% of revenue (top 35%); a gross margin of 21.8% (top 42%) (its annual report).

From the record

The Cigna Group's growth drivers, from the filed years to fiscal 2025: revenue grew 15% a year over the last three filed years against 23.9% over all 10, slowing (bottom 15% of its family); the newest year grew 11.2% (bottom 15%); capital spending grew 31.6% a year (top 5%) (its annual reports). The Cigna Group reported 3 lines of business in fiscal 2025: Evernorth at $235 billion, Cigna Healthcare at $47 billion, All Other at $674 million. 1 of 3 grew in the latest filed year, and the largest line is 83% of revenue (its annual report).

From the record

The Cigna Group's newest year against its own record: revenue of $275 billion in fiscal 2025 came in 4.9% below the $289 billion its prior three years' pace pointed to (bottom 25% of its family); net income of $6.3 billion against a prior three-year average of $5.3 billion (top 35%); a net margin of 2.3% against 2.7% before (top 45%) (its annual reports).